© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
December 13, 2009
A study recommends use of trastuzumab concurrently with the taxane portion of chemotherapy for breast cancer patients.
In the BIG 1-98 trial, high-risk patients did best with 5 years of letrozole and low-risk patients did similarly well with any of the trial%u2019s regimens.
December 11, 2009
Letrozole treatment over 5 years was still associated with significantly better overall survival than 5 years with tamoxifen.
Noah Rindos, MD, Talks Fibroids, Adenomyosis and Pregnancy
Kausik Ray, MD: A Risk-Based Look at LDL Cholesterol Lowering
Jennifer Green, MD: Outcomes, Impact of SGLT2i, GLP-1 RA Combination Therapy